Consultation on Clinical Commissioning Policy Proposition: Bortezomib for relapsed/refractory mantle cell lymphoma

Closed 17 Sep 2017

Opened 18 Aug 2017

Contact

Katie Jones

(Project manager)

Specialised Commissioning

07860180392

Katie.jones19@nhs.net

Overview

NHS England has today (18 August 2017) launched a 30 day public consultation on a clinical commissioning policy for Bortezomib for relapsed/refractory mantle cell lymphoma. There has already been extensive engagement on this policy, it has been developed with the support and input of lead clinicians and patient and public representatives.

This approach has helped ensure that the views of key stakeholders have informed and influenced the development of this policy to date. We now wish to test it further with wider groups of stakeholders.

Related documents

Clinical Commissioning Policies

Bortezomib for relapsed/refractory mantle cell lymphoma:

Audiences

  • Academic/professional institutions
  • Advocacy or support organisations
  • All interested stakeholders
  • All NHS England Staff
  • All P&I staff
  • Allied health professionals
  • Area Team directors
  • Care Quality Commission
  • Care-givers
  • Carers
  • Charities
  • Childcare providers
  • Chiropodists/podiatrists
  • Clinical Nurse Specialist
  • Clinical psychologists
  • Clinicians
  • Commissioners
  • Community groups
  • Community healthcare trusts
  • Deaneries
  • Dental surgeons
  • DH third sector strategic partners
  • Diagnostic radiographers
  • Dietitians
  • Directors of public health
  • Doctors
  • Employee representatives
  • Employer representatives
  • Foundation trusts
  • GP Practices
  • GP Practices
  • GPs
  • Health and Social Care Information Centre
  • Health and Wellbeing boards
  • Health care assistants
  • Health Education England
  • Health Protection Agency
  • Health visitors
  • Healthcare scientists
  • Healthwatch (national and local)
  • Higher education institutions
  • Informatics professionals
  • Information professionals
  • Information providers
  • Local authorities
  • Local Government Association
  • Managers
  • Mental health trusts
  • Midwives
  • Monitor
  • National directors
  • National Institute for Health and Care Excellence
  • Neonatal and maternity staff
  • NHS England Partnership Organisations
  • NHS Trust Development Authority
  • Nurses
  • Occupation therapists
  • Ophthalmic practitioners
  • Orthopists
  • Orthotists
  • Paediatric neuropsychologists
  • Paramedics
  • Patients
  • Pharmaceutical Industry
  • Pharmacists
  • Physiotherapists
  • Policy leads
  • Practice managers
  • Primary care
  • Prosthesists
  • Receptionists
  • Regional directors
  • Regulatory bodies
  • Responsible officers
  • Retailers
  • Royal Colleges
  • Service providers
  • Service users
  • Social care providers
  • Speech and language therapists
  • Strategic clinical networks (SCNs)
  • Suppliers
  • Therapeutic radiographers
  • Trade unions
  • Tribunal service
  • Voluntary groups

Interests

  • Specialised commissioning